D.E. Shaw & Co’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.03M Sell
203,925
-57,207
-22% -$1.69M ﹤0.01% 1329
2025
Q1
$7.79M Buy
261,132
+43,319
+20% +$1.29M 0.01% 1129
2024
Q4
$6.24M Sell
217,813
-47,789
-18% -$1.37M ﹤0.01% 1199
2024
Q3
$10.3M Buy
265,602
+66,739
+34% +$2.58M 0.01% 940
2024
Q2
$6.4M Sell
198,863
-286
-0.1% -$9.21K 0.01% 1143
2024
Q1
$7.73M Sell
199,149
-22,356
-10% -$868K 0.01% 1055
2023
Q4
$6.82M Buy
221,505
+76,353
+53% +$2.35M 0.01% 1054
2023
Q3
$3.24M Buy
145,152
+33,505
+30% +$749K ﹤0.01% 1452
2023
Q2
$2.4M Sell
111,647
-33,048
-23% -$710K ﹤0.01% 1649
2023
Q1
$3.47M Buy
144,695
+120,621
+501% +$2.89M ﹤0.01% 1550
2022
Q4
$559K Buy
24,074
+1,510
+7% +$35K ﹤0.01% 2672
2022
Q3
$361K Sell
22,564
-1,804
-7% -$28.9K ﹤0.01% 3009
2022
Q2
$432K Sell
24,368
-106,596
-81% -$1.89M ﹤0.01% 3108
2022
Q1
$2.67M Buy
130,964
+11,659
+10% +$237K ﹤0.01% 2221
2021
Q4
$2.23M Buy
119,305
+73,226
+159% +$1.37M ﹤0.01% 2307
2021
Q3
$910K Buy
+46,079
New +$910K ﹤0.01% 2536
2020
Q1
Sell
-53,749
Closed -$1.11M 2682
2019
Q4
$1.11M Buy
53,749
+5,823
+12% +$120K ﹤0.01% 1870
2019
Q3
$550K Buy
47,926
+29,990
+167% +$344K ﹤0.01% 2062
2019
Q2
$236K Sell
17,936
-119,081
-87% -$1.57M ﹤0.01% 2370
2019
Q1
$2.07M Buy
+137,017
New +$2.07M ﹤0.01% 1551
2018
Q3
Sell
-29,455
Closed -$703K 2545
2018
Q2
$703K Sell
29,455
-80,517
-73% -$1.92M ﹤0.01% 2024
2018
Q1
$2.81M Sell
109,972
-117,300
-52% -$3M ﹤0.01% 1345
2017
Q4
$4.2M Buy
227,272
+78,017
+52% +$1.44M 0.01% 1154
2017
Q3
$1.57M Buy
149,255
+245
+0.2% +$2.57K ﹤0.01% 1591
2017
Q2
$1.86M Buy
149,010
+5,527
+4% +$69.1K ﹤0.01% 1465
2017
Q1
$1.44M Buy
+143,483
New +$1.44M ﹤0.01% 1527
2016
Q2
Sell
-19,383
Closed -$352K 2532
2016
Q1
$352K Buy
19,383
+9,579
+98% +$174K ﹤0.01% 2195
2015
Q4
$270K Buy
+9,804
New +$270K ﹤0.01% 2327